Cargando…
Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study
BACKGROUND: Metagenomic next-generation sequencing of microbial cell-free DNA (mcfDNA) allows for non-invasive pathogen detection from plasma. However, there is little data describing the optimal role for this assay in real-world clinical decision making. METHODS: We performed a single-center retros...
Autores principales: | Shishido, Akira A., Noe, Myint, Saharia, Kapil, Luethy, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006594/ https://www.ncbi.nlm.nih.gov/pubmed/35418022 http://dx.doi.org/10.1186/s12879-022-07357-8 |
Ejemplares similares
-
Plasma metagenomic next-generation sequencing of microbial cell-free DNA detects pathogens in patients with suspected infected pancreatic necrosis
por: Hong, Donghuang, et al.
Publicado: (2022) -
Identification of Intestinal Microbial Community in Gallstone Patients with Metagenomic Next-Generation Sequencing
por: Ding, Li, et al.
Publicado: (2023) -
Evaluation of a Next-Generation Sequencing Metagenomics Assay to Detect and Quantify DNA Viruses in Plasma from Transplant Recipients
por: Sam, Soya S., et al.
Publicado: (2021) -
878. Clinical impact of plasma cell-free metagenomic next-generation sequencing: A retrospective cohort study
por: Vasishta, Shilpa, et al.
Publicado: (2023) -
Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia
por: Benamu, Esther, et al.
Publicado: (2021)